Study: NCT02711462

Intervention type: DRUG
Group type: OTHER
Intervention: PF-06687234
Description: PF-06687234 will be administered via the SC or the IV route and in either single dose or multiple doses

Intervention type: DRUG
Group type: OTHER
Intervention: PF-06687234
Description: PF-06687234 will be administered via the SC or the IV route and in either single dose or multiple doses

Intervention type: DRUG
Group type: OTHER
Intervention: PF-06687234
Description: PF-06687234 will be administered via the SC or the IV route and in either single dose or multiple doses

Intervention type: DRUG
Group type: OTHER
Intervention: PF-06687234
Description: PF-06687234 will be administered via the SC or the IV route and in either single dose or multiple doses

Intervention type: DRUG
Group type: OTHER
Intervention: PF-06687234
Description: PF-06687234 will be administered via the SC or the IV route and in either single dose or multiple doses

Intervention type: DRUG
Group type: OTHER
Intervention: PF-06687234
Description: PF-06687234 will be administered via the SC or the IV route and in either single dose or multiple doses

Intervention type: DRUG
Group type: OTHER
Intervention: PF-06687234
Description: PF-06687234 will be administered via the SC or the IV route and in either single dose or multiple doses

Intervention type: DRUG
Group type: OTHER
Intervention: PF-06687234
Description: PF-06687234 will be administered via the SC or the IV route and in either single dose or multiple doses

Intervention type: DRUG
Group type: OTHER
Intervention: PF-06687234
Description: PF-06687234 will be administered via the SC or the IV route and in either single dose or multiple doses

Intervention type: DRUG
Group type: OTHER
Intervention: PF-06687234
Description: PF-06687234 will be administered via the SC or the IV route and in either single dose or multiple doses

Intervention type: DRUG
Group type: OTHER
Intervention: PF-06687234
Description: PF-06687234 will be administered via the SC or the IV route and in either single dose or multiple doses

Intervention type: DRUG
Group type: OTHER
Intervention: Placebo
Description: In Cohorts 1 and 2, up to 1 subject will receive placebo. In all other Cohorts (Cohorts 3 to 11), up to 2 subjects will receive placebo.

Intervention type: DRUG
Group type: OTHER
Intervention: Placebo
Description: In Cohorts 1 and 2, up to 1 subject will receive placebo. In all other Cohorts (Cohorts 3 to 11), up to 2 subjects will receive placebo.

Intervention type: DRUG
Group type: OTHER
Intervention: Placebo
Description: In Cohorts 1 and 2, up to 1 subject will receive placebo. In all other Cohorts (Cohorts 3 to 11), up to 2 subjects will receive placebo.

Intervention type: DRUG
Group type: OTHER
Intervention: Placebo
Description: In Cohorts 1 and 2, up to 1 subject will receive placebo. In all other Cohorts (Cohorts 3 to 11), up to 2 subjects will receive placebo.

Intervention type: DRUG
Group type: OTHER
Intervention: Placebo
Description: In Cohorts 1 and 2, up to 1 subject will receive placebo. In all other Cohorts (Cohorts 3 to 11), up to 2 subjects will receive placebo.

Intervention type: DRUG
Group type: OTHER
Intervention: Placebo
Description: In Cohorts 1 and 2, up to 1 subject will receive placebo. In all other Cohorts (Cohorts 3 to 11), up to 2 subjects will receive placebo.

Intervention type: DRUG
Group type: OTHER
Intervention: Placebo
Description: In Cohorts 1 and 2, up to 1 subject will receive placebo. In all other Cohorts (Cohorts 3 to 11), up to 2 subjects will receive placebo.

Intervention type: DRUG
Group type: OTHER
Intervention: Placebo
Description: In Cohorts 1 and 2, up to 1 subject will receive placebo. In all other Cohorts (Cohorts 3 to 11), up to 2 subjects will receive placebo.

Intervention type: DRUG
Group type: OTHER
Intervention: Placebo
Description: In Cohorts 1 and 2, up to 1 subject will receive placebo. In all other Cohorts (Cohorts 3 to 11), up to 2 subjects will receive placebo.

Intervention type: DRUG
Group type: OTHER
Intervention: Placebo
Description: In Cohorts 1 and 2, up to 1 subject will receive placebo. In all other Cohorts (Cohorts 3 to 11), up to 2 subjects will receive placebo.

Intervention type: DRUG
Group type: OTHER
Intervention: Placebo
Description: In Cohorts 1 and 2, up to 1 subject will receive placebo. In all other Cohorts (Cohorts 3 to 11), up to 2 subjects will receive placebo.